“This is useful for the next step, which would be to develop core outcome sets, which are an agreed upon minimum set of outcomes that should be examined in a given disease area,” Dr. Saldanha explained.
Dr. Saldanha reported no relevant financial disclosures. The meeting was sponsored by Johns Hopkins University and the National Institutes of Health.
SOURCE: Saldanha I et al. International Symposium on Sjogren’s Syndrome.